$60 million to study common diseases
The McDonnell Genome Institute at Washington University School of Medicine in St. Louis will receive $60 million from the National Institutes of Health (NIH) to study the genetics of common diseases, such as heart disease, diabetes, stroke, autism and epilepsy.
The cat’s meow: Genome reveals clues to domestication
Cats and humans have shared the same households for at least 9,000 years, but we still know very little about how our feline friends became domesticated. An analysis of the cat genome by School of Medicine researchers reveals some surprising clues. Pictured is a blue Abyssinian cat.
Many older people have mutations linked to leukemia, lymphoma in their blood cells
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research led by Li Ding, PhD, at the School of Medicine.
Rare gene variant linked to macular degeneration
Scientists at The Genome Institute at Washington University School of Medicine helped lead an international team of researchers who have identified a genetic mutation linked to age-related macular degeneration (AMD), the leading cause of blindness in Americans over age 50. Shown is an eye with signs of macular degeneration.
Genome Institute receives $114 million grant
Washington University’s Genome Institute has received a $114 million grant to continue its groundbreaking genomic research. The four-year grant comes from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH). The university’s Genome Institute is one of only three large federally funded genome centers in the United States.
Washington People: Matthew J. Ellis
Breast cancer expert Matthew Ellis, MD, PhD, works with the Genome Institute at Washington University to sequence entire breast cancer genomes — the billions of “letters” making up a person’s DNA. The goal is to unlock the mysteries of breast cancer and tailor treatments to individual patients.